Cargando…

Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis

BACKGROUND: Most cancers maintain telomeres by activating telomerase but a significant minority, mainly of mesenchymal origin, utilize an alternative lengthening of telomeres (ALT) mechanism. METHODS: In this study we comparatively analyzed the prognostic relevance of ALT in a monoinstitutional seri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venturini, Lorenza, Motta, Rosita, Gronchi, Alessandro, Daidone, MariaGrazia, Zaffaroni, Nadia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894794/ https://www.ncbi.nlm.nih.gov/pubmed/20525266 http://dx.doi.org/10.1186/1471-2407-10-254

Ejemplares similares

High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma
por: Cairney, C J, et al.
Publicado: (2008)

A gene expression signature classifying telomerase and ALT immortalisation reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT
por: Lafferty-Whyte, Kyle, et al.
Publicado: (2009)

Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma
por: Alessandrini, Irene, et al.
Publicado: (2022)

Breast Cancer-Initiating Cells: Insights into Novel Treatment Strategies
por: Santilli, Guido, et al.
Publicado: (2011)

Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma
por: Cui, Lixuan, et al.
Publicado: (2021)

High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma
por: Colia, Vittoria, et al.
Publicado: (2017)

Prognostic factors of metastatic myxoid liposarcoma
por: Shinoda, Yusuke, et al.
Publicado: (2020)

High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma
por: Sanfilippo, Roberta, et al.
Publicado: (2014)

Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
por: Zuco, Valentina, et al.
Publicado: (2021)

Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke
por: Ahmadabad, Mona Asghari, et al.
Publicado: (2022)

Prognostic Factors and Survival in Pediatric and Adolescent Liposarcoma
por: Stanelle, Eric J., et al.
Publicado: (2012)

Prognostic value of nuclear morphometry in myxoid liposarcoma
por: Kawaguchi, Kengo, et al.
Publicado: (2023)

Identification of a gene expression driven progression pathway in myxoid liposarcoma
por: De Cecco, Loris, et al.
Publicado: (2014)

Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin
por: Fabbroni, Chiara, et al.
Publicado: (2021)

Galerie Alte Meister /
Publicado: (1979)

Alte nationalgalerie Berlin

Ctrl alt share
Publicado: (2015)

The Alt-Scherbitz Asylum
Publicado: (1898)

Alt HealthWatch
por: Christianson, Merete
Publicado: (2017)

Effects of BRCA2 deficiency on telomere recombination in non-ALT and ALT cells
por: Sapir, Ester, et al.
Publicado: (2011)

G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells
por: Amato, Roberta, et al.
Publicado: (2020)

Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
por: Takeuchi, Akihiko, et al.
Publicado: (2016)

Occurrence of colonic liposarcoma after retroperitoneal liposarcoma
por: Choi, Jin Hwa, et al.
Publicado: (2015)

Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
por: Colomba, Johann, et al.
Publicado: (2019)

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
por: Bello, Ezia, et al.
Publicado: (2019)

Prognostic Value of the AST/ALT Ratio versus Bilirubin in Patients with Cardiogenic Shock
por: Schupp, Tobias, et al.
Publicado: (2023)

Nuclear envelope tethering inhibits the formation of ALT-associated PML bodies in ALT cells
por: Yang, Chia-Wei, et al.
Publicado: (2021)

Dedifferentiated liposarcomas: evaluation of the prognostic and therapeutic factors in the elderly patient
por: Amodeo, C, et al.
Publicado: (2010)

Retroperitoneal liposarcoma: the role of adjuvant radiation therapy and the prognostic factors
por: Lee, Hong Seok, et al.
Publicado: (2016)

Prognostic factors of patients with extremity myxoid liposarcomas after surgery
por: Wu, Jiaqi, et al.
Publicado: (2019)

Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
por: Bello, Ezia, et al.
Publicado: (2020)

Astrofisica delle alte energie
por: Vietri, Mario
Publicado: (2006)

Telomere clustering drives ALT
por: Min, Jaewon, et al.
Publicado: (2019)

Liposarcoma :Revisión Bibliográfica/
por: Patatuchi Oseguera, Víctor Manuel
Publicado: (1986)

Alt-Mexiko : archäologische beiträge zur kulturgeschichte seiner bewohner /
por: Strebel, Hermann, 1834-1914
Publicado: (1885)

Alt-Mexiko : archäologische beiträge zur kulturgeschichte seiner bewohner /
por: Strebel, Hermann, 1834-1914
Publicado: (1889)

miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an “ALT-like” phenotype in diffuse malignant peritoneal mesothelioma cells
por: Cimino-Reale, Graziella, et al.
Publicado: (2017)

Liposarcoma of the colon.
por: Parks, R. W., et al.
Publicado: (1994)

Liposarcoma of the Thyroid
por: Mitra, A., et al.
Publicado: (2004)

Liposarcomas of the mediastinum
por: Suster, David Ilan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jqp3ttt52hsfmgsfk68moeql7i